{"DataElement":{"publicId":"6303294","version":"1","preferredName":"Clinical Study Negation Randomization Reason","preferredDefinition":"The explanation for why the patient was not randomized to a study.","longName":"RSN_NOT_RAND","context":"CCTG","contextVersion":"1","DataElementConcept":{"publicId":"6303284","version":"1","preferredName":"Clinical Study Negation Randomization","preferredDefinition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research._An operation in which a term denies or inverts the meaning of another term or construction._The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.","longName":"2430995v1.0:6303282v1.0","context":"CCTG","contextVersion":"1","ObjectClass":{"publicId":"2430995","version":"1","preferredName":"Study","preferredDefinition":"A type of research study that tests how well new medical treatments or other interventions work in people.  Such studies test new methods of screening, prevention, diagnosis, or treatment of a disease.  The study may be carried out in a clinic or other medical facility.  Also called a clinical trial.","longName":"C15206","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical Study","conceptCode":"C15206","definition":"Research conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, study of mechanisms of human diseases, therapy, clinical trials, epidemiologic, behavior, and health services research.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05D7809E-DF10-22B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-11-18","modifiedBy":"ONEDATA","dateModified":"2005-11-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6303282","version":"1","preferredName":"Negation Randomization","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.:The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.","longName":"C25594:C25196","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Randomization","conceptCode":"C25196","definition":"The allocation of individuals to groups by chance, especially in order to control the variables in an experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CFA64B5-7684-2D9B-E053-F662850A88A3","latestVersionIndicator":"Yes","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"ONEDATA","dateModified":"2018-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CFA64B5-7695-2D9B-E053-F662850A88A3","latestVersionIndicator":"Yes","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"TAYLORT","dateModified":"2018-11-26","changeDescription":"11/26/18 TT released/CWinch. 5/24/18 tt/MA39.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6303289","version":"1","preferredName":"Negation Randomization Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"6303289v1.0","context":"CCTG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5043360","version":"1","preferredName":"Not Applicable","longName":"5043360","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2421E11B-65A6-151D-E050-BB89AD4378BB","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"DWARZEL","dateModified":"2018-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CF83250-76D7-1DC8-E053-F662850A8CF5","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"ONEDATA","dateModified":"2018-05-24","deletedIndicator":"No"},{"value":"Other reason, specify","valueDescription":"Other Reason Specify","ValueMeaning":{"publicId":"2768992","version":"1","preferredName":"Other Reason Specify","longName":"2768992","preferredDefinition":"Not otherwise specified.: An explanation of the cause of some phenomenon or action.: Specify; be specific about something; define clearly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9824-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CF83250-76E2-1DC8-E053-F662850A8CF5","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"ONEDATA","dateModified":"2018-05-24","deletedIndicator":"No"},{"value":"Patient choice","valueDescription":"Patient Choice","ValueMeaning":{"publicId":"6303290","version":"1","preferredName":"Patient Choice","longName":"6303290","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.: Select from a group.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Choose","conceptCode":"C48912","definition":"Select from a group.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CF83250-76F0-1DC8-E053-F662850A8CF5","latestVersionIndicator":"Yes","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"TAYLORT","dateModified":"2018-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CF83250-7709-1DC8-E053-F662850A8CF5","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"ONEDATA","dateModified":"2018-05-24","deletedIndicator":"No"},{"value":"Specify protocol criterion","valueDescription":"Specify Clinical Trial Eligibility Criteria","ValueMeaning":{"publicId":"6303291","version":"1","preferredName":"Specify Clinical Trial Eligibility Criteria","longName":"6303291","preferredDefinition":"Be specific about something; define clearly.: Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CF83250-7716-1DC8-E053-F662850A8CF5","latestVersionIndicator":"Yes","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"ONEDATA","dateModified":"2018-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CF83250-772F-1DC8-E053-F662850A8CF5","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"ONEDATA","dateModified":"2018-05-24","deletedIndicator":"No"},{"value":"Other eligibility criteria not met","valueDescription":"Other Clinical Trial Eligibility Criteria Negation Fulfill","ValueMeaning":{"publicId":"6303292","version":"1","preferredName":"Other Clinical Trial Eligibility Criteria Negation Fulfill","longName":"6303292","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.: An operation in which a term denies or inverts the meaning of another term or construction.: Satisfy the requirements or expectations of.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fulfill","conceptCode":"C87531","definition":"Satisfy the requirements or expectations of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CF83250-773E-1DC8-E053-F662850A8CF5","latestVersionIndicator":"Yes","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"ONEDATA","dateModified":"2018-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CF83250-7757-1DC8-E053-F662850A8CF5","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"ONEDATA","dateModified":"2018-05-24","deletedIndicator":"No"},{"value":"Patient had an Oncotype DX score of 18 or greater","valueDescription":"Oncotype DX Breast Cancer Assay Score Value Or Greater","ValueMeaning":{"publicId":"6303293","version":"1","preferredName":"Oncotype DX Breast Cancer Assay Score Value Or Greater","longName":"6303293","preferredDefinition":"A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX is validated for use in breast cancer patients whose disease is newly diagnosed, stage I or II, node-negative, estrogen receptor-positive and who will be treated with tamoxifen.: A number or range of numeric values measuring performance, function, quality, or ability.: A numerical quantity measured or assigned or computed.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Notable in size, number, measure, magnitude, degree, or effectiveness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oncotype DX Breast Cancer Assay","conceptCode":"C52159","definition":"A diagnostic assay that quantifies the likelihood of breast cancer recurrence in women with newly diagnosed, early stage breast cancer. In addition to predicting distant disease recurrence, Oncotype DX also assesses the benefit from certain types of chemotherapy. The assay, performed using formalin-fixed, paraffin-embedded tumor tissue, analyzes the expression of a panel of 21 genes and the results are provided as a Recurrence Score (0-100). The gene panel was selected and the Recurrence Score calculation was derived through extensive laboratory testing and multiple independent clinical development studies. Oncotype DX is validated for use in breast cancer patients whose disease is newly diagnosed, stage I or II, node-negative, estrogen receptor-positive and who will be treated with tamoxifen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Greater","conceptCode":"C61421","definition":"Notable in size, number, measure, magnitude, degree, or effectiveness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CF83250-7767-1DC8-E053-F662850A8CF5","latestVersionIndicator":"Yes","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"ONEDATA","dateModified":"2018-05-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CF83250-7780-1DC8-E053-F662850A8CF5","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"ONEDATA","dateModified":"2018-05-24","deletedIndicator":"No"},{"value":"Confirmatory typing revealed no 8/8 MUD","valueDescription":null,"ValueMeaning":{"publicId":"14540855","version":"1","preferredName":"Confirmation HLA Typing Negation 8/8 HLA Match Matched Unrelated Donor","longName":"14540855v1.00","preferredDefinition":"Having been established or verified._A process in which blood or tissue samples are analyzed to determine their human leukocyte antigen (HLA) profiles._An operation in which a term denies or inverts the meaning of another term or construction._Complete HLA matching for HLA-A, -B, -C, and -DRB1 loci._A donor who is not related to the transplant recipient, but who is a human leukocyte antigen (HLA) tissue type match.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"HLA Typing","conceptCode":"C71329","definition":"A process in which blood or tissue samples are analyzed to determine their human leukocyte antigen (HLA) profiles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"8/8 HLA Match","conceptCode":"C158042","definition":"Complete HLA matching for HLA-A, -B, -C, and -DRB1 loci.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Matched Unrelated Donor","conceptCode":"C131676","definition":"A donor who is not related to the transplant recipient, but who is a human leukocyte antigen (HLA) tissue type match.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07FE1A1E-13B6-440B-E063-731AD00ACB19","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"07FE1A1E-13BA-440B-E063-731AD00ACB19","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"},{"value":"Family prefers haploidentical donor","valueDescription":null,"ValueMeaning":{"publicId":"14540856","version":"1","preferredName":"Family Preference Haploidentical","longName":"14540856v1.00","preferredDefinition":"A domestic group, or a number of domestic groups linked through descent (demonstrated or stipulated) from a common ancestor, marriage, or adoption._The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable._A donor who has only one haplotype in common with the recipient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Family","conceptCode":"C25173","definition":"A domestic group, or a number of domestic groups linked through descent (demonstrated or stipulated) from a common ancestor, marriage, or adoption.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Preference","conceptCode":"C41187","definition":"The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Haploidentical","conceptCode":"C111983","definition":"A donor who has only one haplotype in common with the recipient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07FE1A1E-13B7-440B-E063-731AD00ACB19","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"07FE1A1E-13BB-440B-E063-731AD00ACB19","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"},{"value":"Physician prefers haploidentical donor","valueDescription":null,"ValueMeaning":{"publicId":"14540857","version":"1","preferredName":"Physician Preference Haploidentical","longName":"14540857v1.00","preferredDefinition":"A doctor; a person who has been educated, trained, and licensed to practice the art and science of medicine; a practitioner of medicine, as contrasted with a surgeon._The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable._A donor who has only one haplotype in common with the recipient.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Physician","conceptCode":"C25741","definition":"A doctor; a person who has been educated, trained, and licensed to practice the art and science of medicine; a practitioner of medicine, as contrasted with a surgeon.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Preference","conceptCode":"C41187","definition":"The act, fact, or principle of giving advantages to some particular person, object, or course of action over others; designated as more desirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Haploidentical","conceptCode":"C111983","definition":"A donor who has only one haplotype in common with the recipient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07FE1A1E-13B8-440B-E063-731AD00ACB19","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"07FE1A1E-13BC-440B-E063-731AD00ACB19","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"},{"value":"MUD didn’t come in for confirmatory typing","valueDescription":null,"ValueMeaning":{"publicId":"14540858","version":"1","preferredName":"Negation Arrival Confirmation HLA Typing Matched Unrelated Donor","longName":"14540858v1.00","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._The act of reaching a destination._Having been established or verified._A process in which blood or tissue samples are analyzed to determine their human leukocyte antigen (HLA) profiles._A donor who is not related to the transplant recipient, but who is a human leukocyte antigen (HLA) tissue type match.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Arrival","conceptCode":"C53463","definition":"The act of reaching a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Confirmation","conceptCode":"C25458","definition":"Having been established or verified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"HLA Typing","conceptCode":"C71329","definition":"A process in which blood or tissue samples are analyzed to determine their human leukocyte antigen (HLA) profiles.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Matched Unrelated Donor","conceptCode":"C131676","definition":"A donor who is not related to the transplant recipient, but who is a human leukocyte antigen (HLA) tissue type match.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07FE1A1E-13B9-440B-E063-731AD00ACB19","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"07FE1A1E-13BD-440B-E063-731AD00ACB19","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"},{"value":"MUD out of the country/far away from the BMT center","valueDescription":null,"ValueMeaning":{"publicId":"14540859","version":"1","preferredName":"MUD out of the country/far away from the BMT center","longName":"14540859v1.00","preferredDefinition":"MUD out of the country/far away from the BMT center","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07FE2977-20D2-4942-E063-731AD00ABCEC","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"07FE2977-20D6-4942-E063-731AD00ABCEC","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"},{"value":"MUD not willing to donate within the time frame","valueDescription":null,"ValueMeaning":{"publicId":"14540860","version":"1","preferredName":"MUD not willing to donate within the time frame","longName":"14540860v1.00","preferredDefinition":"MUD not willing to donate within the time frame","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07FE2977-20D3-4942-E063-731AD00ABCEC","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"07FE2977-20D7-4942-E063-731AD00ABCEC","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"},{"value":"MUD not willing to donate graft of choice","valueDescription":null,"ValueMeaning":{"publicId":"14540861","version":"1","preferredName":"MUD not willing to donate graft of choice","longName":"14540861v1.00","preferredDefinition":"MUD not willing to donate graft of choice","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07FE2977-20D4-4942-E063-731AD00ABCEC","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"07FE2977-20D8-4942-E063-731AD00ABCEC","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"},{"value":"MUD had unfavorable donor characteristics","valueDescription":null,"ValueMeaning":{"publicId":"14540862","version":"1","preferredName":"MUD had unfavorable donor characteristics","longName":"14540862v1.00","preferredDefinition":"MUD had unfavorable donor characteristics","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"07FE2977-20D5-4942-E063-731AD00ABCEC","latestVersionIndicator":"Yes","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"07FE2977-20D9-4942-E063-731AD00ABCEC","beginDate":"2023-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-10-18","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008528","version":"1","preferredName":"Protocol Administration","preferredDefinition":"the management of a research protocol and its case report forms.","longName":"PROT_ADM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ECAD41-A932-34B1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2240632","version":"1","preferredName":"Reason","preferredDefinition":"An explanation of the cause of some phenomenon or action.","longName":"C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F9FA7953-8391-043D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-30","endDate":null,"createdBy":"PWEST","dateCreated":"2005-06-30","modifiedBy":"ONEDATA","dateModified":"2005-06-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CF83250-76BF-1DC8-E053-F662850A8CF5","latestVersionIndicator":"Yes","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":"11/26/18 TT released/CWinch. 5/24/18 tt/MA39.","administrativeNotes":"2023.10.18 PVs added per ticket request CADSR0002976. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"RSN_NOT_RAND","type":"USED_BY","context":"CCTG"}],"ReferenceDocuments":[{"name":"Please specify the reason(s)","type":"Preferred Question Text","description":"Please specify the reason(s) the patient was not randomized to the MA.39 study.","url":null,"context":"CCTG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Reason patient was not randomized:","url":null,"context":"COG"}],"origin":"CCTG: Canadian Cancer Trials Group","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CFAF0F0-8693-57FA-E053-F662850AEE84","latestVersionIndicator":"Yes","beginDate":"2018-05-24","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-24","modifiedBy":"KUMMEROA","dateModified":"2023-10-18","changeDescription":"11/26/18 TT released/CWinch. 5/24/18 tt/MA39.","administrativeNotes":"2023.10.18 AQT added per ticket request CADSR0002976. ak","unresolvedIssues":null,"deletedIndicator":"No"}}